A Review on Hypertension
DOI:
https://doi.org/10.61841/p02e2982Keywords:
Hypertension, Diagnosis, Management, Self-Monitoring, Technological AdvancementAbstract
Hypertension has been distinguished by WHO as one of the most critical hazardous factors for morbidness and mortality worldwide and is answerable for the passing of roughly 10,000,000 individuals every year. Hypertension is a key hazard factor for cardiovascular illness. Right now, around 33% of individuals with hypertension are undiscovered, and of those analyzed, around half are not taking antihypertensive prescriptions. The World Health Organization (WHO) measures that hypertension straightforwardly causes passing of individuals at a rate of 10,000,000 individuals each year. There is a developing pattern to enable patients to help hypertension screening and diagnosis, and a few examinations have indicated the advantage of tele-checking, especially when combined with co-intercession, in improving the administration of hypertension. In this audit, we look at how rising innovations may bolster improved discovery and the board of hypertension in the more extensive populace as well as inside exceptional populace gatherings, for example, the old, pregnant ladies, and those with atrial fibrillation.
Downloads
References
[1] N. Hasebe, “Hypertension,” Nihon Rinsho., 2015, doi: 10.7748/ns2003.12.18.13.45.c3517.
[2] B. Leeper and B. Powell, “Pulmonary arterial hypertension,” Nurs. Crit. Care, 2019, doi: 10.1097/01.CCN.0000554829.05209.ca.
[3] L. C. Kenny et al., “Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers,” Hypertension, 2010, doi: 10.1161/HYPERTENSIONAHA.110.157297.
[4] K. B. Tibazarwa and A. A. Damasceno, “Hypertension in developing countries,” Canadian Journal of Cardiology. 2014, doi: 10.1016/j.cjca.2014.02.020.
[5] W. F. Young, D. A. Calhoun, J. W. M. Lenders, M. Stowasser, and S. C. Textor, “Screening for endocrine hypertension: An endocrine society scientific statement,” Endocr. Rev., 2017, doi: 10.1210/er.2017-00054.
[6] A. L. Siu et al., “Screening for high blood pressure in adults: U.S. preventive services task force recommendation statement,” Ann. Intern. Med., 2015, doi: 10.7326/M15-2223.
[7] M. M. Hoeper et al., “Definitions and diagnosis of pulmonary hypertension,” in Journal of the American College of Cardiology, 2013, doi: 10.1016/j.jacc.2013.10.032.
[8] N. Galiè et al., “2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension,” Eur. Heart J., 2016, doi:10.1093/eurheartj/ehv317.
[9] L. A. Magee, A. Pels, M. Helewa, E. Rey, and P. Von Dadelszen, “Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy,” Pregnancy Hypertension. 2014, doi: 10.1016/j.preghy.2014.01.003.
[10] J. M. Roberts et al., ACOG Guidelines: Hypertension in pregnancy. 2012.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
